EditorialPublished 23 May 2020

Bridging the Gap in Multiple Sclerosis Rehabilitation During Covid-19

Authors: Eoin Synnott

Journal of Multiple Sclerosis

Volume 7 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In March 2020 the WHO declared that COVID-19 had reached pandemic state. To date the primary focus internationally has been on the preservation of life. For those with pre-existing neurological disease, there is an additional concern with early evidence suggesting this group could be predisposed to adverse outcomes. Multiple sclerosis (MS) patients are a particularly vulnerable group during this pandemic. The combination of an autoimmune neurodegenerative disorder and the immunosuppression caused by the typically prescribed pharmacological agents augments the risk of complications in this group [1]. As a public health precaution, international governmental bodies recommended that people with multiple sclerosis (pwMS) self-isolate as much as possible to reduce their risk of contracting the virus.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Multiple Sclerosis
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Eoin Synnott”